STOCK TITAN

Millennium (MRVI) reports 7.32M shared stake, 4.96% as of Jun 16, 2026

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander filed a Schedule 13G reporting shared beneficial ownership of 7,323,520 shares (4.96%) of Maravai LifeSciences Holdings, Inc. Class A common stock (CUSIP 56600D107) with a June 16, 2026 ownership date.

The filing states the reported shares reflect shared voting and shared dispositive power of 7,323,520 and notes that, after acquiring beneficial ownership of more than 5% on June 16, 2026, the reporting persons ceased to be beneficial owners of more than 5% by the date of this filing. The filing is accompanied by a Joint Filing Agreement dated June 22, 2026.

Positive

  • None.

Negative

  • None.

Insights

Large asset manager reports a passive 4.96% shared stake as of June 16, 2026.

The filing lists 7,323,520 shares held with shared voting and dispositive power by entities managed or controlled by Millennium Management LLC and associates. The statement clarifies group ownership structure and includes a Joint Filing Agreement dated June 22, 2026.

Because the filing reports a 4.96% position and indicates the reporting persons ceased to hold more than 5% by the filing date, this is a routine institutional disclosure of holdings; cash‑flow treatment and trade methods are not provided in the excerpt.

Filing type Schedule 13G Ownership disclosure for Class A common stock
Shared voting/dispositive power 7,323,520 shares Reported on cover rows as shared voting and shared dispositive power
Percent of class 4.96% Percent shown on cover rows, ownership as of <date>June 16, 2026</date>
Ownership date June 16, 2026 Date after which reporting persons ceased to be >5% by filing date
Joint Filing Agreement dated June 22, 2026 Exhibit I to the Schedule 13G
CUSIP 56600D107 Class A Common Stock identifier shown on cover page
Schedule 13G regulatory
"Item 1. | (a) | Name of issuer: Maravai LifeSciences Holdings, Inc."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Shared dispositive power financial
"6 | Shared Voting Power 7,323,520.00 ... 8 | Shared Dispositive Power 7,323,520.00"
Joint Filing Agreement regulatory
"Exhibit I: Joint Filing Agreement, dated as of June 22, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Millennium Management report in Maravai (MRVI)?

They report shared beneficial ownership of 7,323,520 shares, representing 4.96% of Class A common stock as of June 16, 2026. The filing attributes shared voting and dispositive power to the reporting entities.

Did the filing say Millennium still holds more than 5% of MRVI?

No. The filing states the reporting persons acquired beneficial ownership of more than 5% on June 16, 2026 but ceased to be beneficial owners of more than 5% by the filing date, per Item 4 language.

Which entities signed the Schedule 13G for MRVI?

The Schedule 13G was filed by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, and it includes a Joint Filing Agreement dated June 22, 2026 among those parties.

What voting or dispositive power is reported over the shares?

The cover-page entries show shared voting power of 7,323,520 shares and shared dispositive power of 7,323,520 shares, with no sole voting or sole dispositive power reported on the cover rows.

Where is Maravai's principal executive office listed in the filing?

The filing lists Maravai LifeSciences Holdings' principal executive offices at 10770 Wateridge Circle, Suite 200, San Diego, California 92121 in Item 1(b) of the Schedule 13G.





56600D107

(CUSIP Number)
06/16/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/22/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/22/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:06/22/2026
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 22, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.